(NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it has ...
Veltex Corporation (OTCQB: VLXC) ("Veltex") announces the 38th Annual Meeting of Shareholders will be held on Wednesday, December 04, 2024, at the Mount Hope Campus of Veltex Recovery Group. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback